Effect of Huoxue Huayu Detoxification on GSK-3β and β-catenin levels in OSF patients and its mechanism

• 来源期刊: 海南医科大学学报（英文版）
• 年，卷（期）: 2021,（5）
• 所属期刊栏目: Original article
• 页码范围: 28-32
• 页数: 5页
• 语种: 英文

摘要

Objective: To explore the effects of Huoxue Huayu detoxification method on the levels of GSK-3β and β-catenin in OSF patients and its mechanism. Methods: A total of 120 patients with oral submucosal fibrosis (OSF) treated in our hospital from May 2018 to December 2019 were selected and divided into routine treatment group and Huoxue Huayu detoxification group of 60 cases according to the lottery method. The routine treatment group was treated with triamcinolone acetonide injection, and the Huoxue Huayu detoxification group was treated with Huoxue Huayu detoxification. The lesion area, mouth opening degree, SFRP1 level in gingival crevicular fluid and saliva, TCM symptom score, TGF-β1, IL-6, GSK-3β, β-catenin expression and clinical effect were observed in the two groups. Results: After treatment, the lesion area of oral mucosa in the Huoxue Huayu detoxification group was smaller than that in the routine treatment group (P<0.05), and the mouth opening degree in the Huoxue Huayu detoxification group was larger than that in the routine treatment group (P<0.05); After treatment, the level of SFRP1 in gingival crevicular fluid and saliva and clinical effect in the Huoxue Huayu detoxification group were higher than those in the routine treatment group (P<0.05); the TCM syndrome score, TGF-β1, IL-6, GSK-3β, β-catenin expression in the Huoxue Huayu detoxification group were lower than those in the routine treatment group (P<0.05). Conclusion: By acting on Wnt/β-catenin signaling pathway, Huoxue Huayu detoxification method can regulate the expression of TGF-β1, IL-6, GSK-3β, β-catenin, improve the clinical symptoms of patients with oral submucous fibrosis, alleviate the body inflammation, alleviate the pain, with remarkable effect.